176 related articles for article (PubMed ID: 3219156)
21. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.
Mizuno K; Hashimoto S; Yabe R; Kunii N; Niimura S; Tani M; Watari H; Fukuchi S
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):3-15. PubMed ID: 3520729
[TBL] [Abstract][Full Text] [Related]
22. Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites.
Ishii A; Nishida K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1681-3. PubMed ID: 3219140
[TBL] [Abstract][Full Text] [Related]
23. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
[TBL] [Abstract][Full Text] [Related]
24. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
25. Gas chromatographic method for the quantification of the new calcium antagonist benidipine hydrochloride in plasma using electron capture detection.
Kobayashi H; Kobayashi S; Inoue A; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1730-3. PubMed ID: 3219149
[TBL] [Abstract][Full Text] [Related]
26. Identification of benidipine hydrochloride metabolites in rats and dogs.
Kobayashi H; Okumura S; Kosaka Y; Kobayashi S; Inoue A; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1753-6. PubMed ID: 3219155
[TBL] [Abstract][Full Text] [Related]
27. Sensitive radioreceptor assay of the calcium antagonist benidipine hydrochloride in plasma and urine.
Ishii A; Nishida K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1733-7. PubMed ID: 3219150
[TBL] [Abstract][Full Text] [Related]
28. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
[TBL] [Abstract][Full Text] [Related]
29. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
30. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
[TBL] [Abstract][Full Text] [Related]
31. Benidipine hydrochloride (KW-3049): a new dihydropyridine calcium antagonist.
Arzneimittelforschung; 1988 Nov; 38(11A):1661-763. PubMed ID: 3219136
[No Abstract] [Full Text] [Related]
32. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
Leonetti G;
Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
[TBL] [Abstract][Full Text] [Related]
33. Physico-chemical properties and stabilities of the highly potent calcium antagonist benidipine hydrochloride.
Suzuki H; Ono E; Ueno H; Takemoto Y; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1671-6. PubMed ID: 3219139
[TBL] [Abstract][Full Text] [Related]
34. Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension.
Esper RJ; Esper RC; Baglivo HP; Castro JM; Rohwedder RW; Menna J
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1096-9. PubMed ID: 6085374
[TBL] [Abstract][Full Text] [Related]
35. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
36. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
Weigmann I; Terhaag B; Wierich W; Herrmann WM
Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Yamaura T; Kase N; Kita H; Uematsu T
Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
[TBL] [Abstract][Full Text] [Related]
38. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
[TBL] [Abstract][Full Text] [Related]
39. Nilvadipine in hypertension--experience in ambulatory treatment.
Hoffmann A; Kraul H; Burkardt I
Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874
[TBL] [Abstract][Full Text] [Related]
40. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
Bühler G; Wadepuhl M; Nandi K; Rosenthal J
Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
